Avanos Medical, Inc.
AVNS
$13.11
-$0.01-0.08%
NYSE
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 1.74% | 1.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.74% | 1.60% | |||
| Cost of Revenue | 3.38% | 10.74% | |||
| Gross Profit | 0.00% | -6.62% | |||
| SG&A Expenses | 15.80% | -7.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -160.87% | 666.67% | |||
| Total Operating Expenses | 0.00% | 2.78% | |||
| Operating Income | 620.00% | -80.00% | |||
| Income Before Tax | 200.00% | 98.42% | |||
| Income Tax Expenses | 1,150.00% | -77.78% | |||
| Earnings from Continuing Operations | 7.14% | 98.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.14% | 98.18% | |||
| EBIT | 620.00% | -80.00% | |||
| EBITDA | 36.36% | -20.80% | |||
| EPS Basic | 7.28% | 98.18% | |||
| Normalized Basic EPS | 387.04% | -172.97% | |||
| EPS Diluted | 7.28% | 98.18% | |||
| Normalized Diluted EPS | 387.04% | -172.97% | |||
| Average Basic Shares Outstanding | 0.00% | 0.22% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||